Blocknomi
Key Takeaways Shares of Novartis climbed approximately 5% following positive Phase 3 trial outcomes for remibrutinib, an oral multiple sclerosis treatment The experimental drug outperformed teriflunomide (marketed as Aubagio by…
Related articles
-
Banks weigh stablecoins as payments competition grows: WSJ
Crypto.News Published 27.08.2026 05:07
-
Uniswap Trading Volume Increases $325M as Stock Tokens Expand
Blocknomi Published 29.08.2026 02:22
-
Binance to Delist 12 Margin Pairs at Start of September: SUI, AVAX, LINK Affected
U.Today Published 31.08.2026 12:55
-
Kalshi Faces Connecticut Crackdown as Legal Battle Deepens
Blocknomi Published 27.08.2026 06:26
-
XRP Records $4B+ in Stablecoin Transfer Volume as Holders Spike 36% to 82,000+
The Crypto Basic Published 19.08.2026 12:52
-
CYBERLEEK Meme Coin Explodes 1,400% Amid GTA VI Leak Controversy
BeInCrypto Published 23.08.2026 14:26
-
Bitcoin price hits 11-week high as US Treasury doubles debt buyback size
Cointelegraph Published 19.08.2026 15:44
-
How Tokenized Stock Transfer Volume Differs From Market Value
Crypto Daily Published 30.08.2026 15:21